Gemigliptin Market is witnessing a Tremendous Rise in its Valuation | GIS Study
Gemigliptin is a new drug developed by Daiichi Sankyo, Inc. It is an oral dipeptidyl peptidase-4 (DPP-4) inhibitor, used to treat type 2 diabetes mellitus. …
Gemigliptin Market Trends